Developing a high fibre carbonated soft drink with improved digestive tolerance and beneficial impacts on the gut microbiome: FUNKi-2.0

开发一种高纤维碳酸软饮料，可改善消化耐受性并对肠道微生物群产生有益影响：FUNKi-2.0

• 批准号: 10066535
• 金额: $ 22.47万
• 依托单位: FUNKI DRINKS LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10066535
• 关键词: Developing; fibre; carbonated; soft; drink

Our vision is to develop a novel carbonated soft drink fortified with a fibre-blend with evidence-based benefits to gut microbes that offers a tasty, convenient and affordable way for the UK to easily achieve their recommended fibre intake of 30g each day.An initial assessment of the current carbonated drink formulation (FUNKi-1.0) on the gut microbiome using advanced _in vitro_ colonic fermentation models at Quadram Institute (QI) will identify an optimal fibre-blend for reformulation. This project will enable FUNKi to launch the UK's first carbonated soft drink fortified with a fibre-blend (FUNKi-2.0) that has proven digestive tolerance, benefits to gut microbes and potential to improve human health.FUNKi-2.0 will enable consumers to increase their fibre intake in a novel and innovative way that is convenient. Eating plenty of fibre is associated with lower risks of heart disease, stroke, type 2 diabetes and bowel cancer (NHS). Despite this, only 9% of the UK population achieve the recommended fibre intake of 30g per day! (FDF). The UK's appetite for CSDs is growing with annual consumption rising from 4.6 billion litres in 2021 to an estimated 4.9 billion litres in 2026\. This concept of providing optimal fibre intake in CSDs is powerful; if only 1% of the UK had one can of FUNKi-2.0 each day, that would mean 6.7 million more people would achieve their dietary fibre intake and reduce their risk of cardiovascular disease and obesity - helping to offset the 9% of all NHS spend on diet-related chronic disease and the estimated £49.9 billion wider societal costs predicted to arise from obesity by 2050\.

我们的愿景是开发一种新型的碳酸软饮料，用纤维混合物强化，对肠道微生物有基于证据的益处，方便和负担得起的方式为英国轻松实现他们的建议纤维摄入量30克每天。目前的碳酸饮料配方的初步评估Quadram研究所（QI）使用先进的体外结肠发酵模型对肠道微生物组进行的FUNKi-1.0研究将确定用于重新配制的最佳纤维混合物。该项目将使FUNKi能够推出英国首款添加纤维混合物的碳酸软饮料（FUNKi-2.0），该产品已被证明具有消化耐受性，有益于肠道微生物，并具有改善人体健康的潜力。FUNKi-2.0将使消费者能够以新颖和创新的方式增加纤维摄入量。吃大量的纤维与降低心脏病，中风，2型糖尿病和肠癌（NHS）的风险有关。尽管如此，只有9%的英国人口达到了每天30克的推荐纤维摄入量！（FDF）。英国对CSD的需求正在增长，年消费量从2021年的46亿升增加到2026年的49亿升。在CSD中提供最佳纤维摄入量的概念是强大的;如果英国只有1%的人每天有一罐FUNKi-2.0，这将意味着670多万人将达到他们的膳食纤维摄入量，并降低他们患心血管疾病和肥胖症的风险-有助于抵消所有NHS饮食支出的9%-相关的慢性疾病和估计的499亿英镑的更广泛的社会成本预计到2050年将由肥胖引起。